| Metric | H2 FY26 | H1 FY26 | |
|---|---|---|---|
| Revenue from operations | 39.9 | 43.2 | — |
| Other income | 0.4 | 0.6 | — |
| Total income | 40.3 | 43.8 | — |
| Profit before exceptional items & tax | 1.2 | 4.8 | — |
| Profit before tax | 1.2 | 4.8 | — |
| Net profit | 2.1 | 3.2 | — |
| Operating margin | 3.0% | 11.0% | — |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -34.40% |
|---|
BSE results filing, BSE: 544673. Figures extracted from the filing.
Modern Diagnostic & Research Centre Ltd: key numbers
- Share price
- ₹75.75
- Market cap
- ₹114.4 Cr
- Revenue (annual)
- ₹83.11 Cr
- Net profit (annual)
- ₹5.25 Cr
- P/E (TTM)
- 21.8×Sector 57.8×
- Promoter holding
- 72.85%
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Modern Diagnostic & Research Centre Ltd
All →Modern Diagnostic & Research Centre Price Movement Clarification
Modern Diagnostic & Research Centre Ltd clarified its share price movement is purely market-driven. No undisclosed or price-sensitive information exists requiring disclosure under SEBI Regulations.
Modern Diagnostic & Research Centre Annual Report
Modern Diagnostic & Research Centre has submitted its Annual Report and Notice of the 14th Annual General Meeting for the financial year 2025-26.
Modern Diagnostic & Research Centre Annual General Meeting
Modern Diagnostic & Research Centre Limited has scheduled its 14th Annual General Meeting for September 30, 2026. The book closure is from September 24 to 30.
Modern Diagnostic & Research Centre Board Meeting Outcome
Modern Diagnostic & Research Centre approved various routine matters, including AGM notice, director reappointment, and statutory auditor reappointment. It also terminated a Jaipur laboratory management agreement.